News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Valeant Pharmaceuticals International (VRX) Will Sweeten $46 Billion Allergan Inc. (AGN) Bid


5/13/2014 7:44:58 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Valeant Pharmaceuticals says it will upgrade its unsolicited bid to buy specialty drugmaker Allergan for nearly $46 billion, and it wants to tell Allergan shareholders why it offers the better deal. The Canadian drugmaker says it will host a webcast later this month to explain why the cash-and-stock offer it announced last month is better than Allergan's plan to continue running as a stand-alone company. Valent says it will improve its offer to show its commitment to getting a deal done.

Help employers find you! Check out all the jobs and post your resume.

Read at CBC
Read at CNN Money
Read at News Release
Read at Nasdaq


comments powered by Disqus
CBC
CNN Money
News Release
Nasdaq
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES